# Regulatory Compliance
Latest news and articles about Regulatory Compliance
Total: 5 articles found
The 30,000-Yuan Red Line: China’s Healthcare Sector Reels Under Strict New Anti-Bribery Rules
China has introduced a strict new judicial interpretation lowering the criminal prosecution threshold for healthcare bribery to 30,000 RMB, triggering widespread panic among doctors and pharmaceutical firms. The move targets both public and private sectors, holding companies liable for employee misconduct and signaling an end to the era of relationship-based medical sales.
Beijing Reins in Micromobility Giants: HelloBike Penalized Amidst Regulatory Crackdown
Beijing transport authorities are penalizing HelloBike for the illegal deployment of unregistered bicycles and failure to comply with rectification orders. The company faces administrative fines and a significant reduction in its permitted operating scale as the city tightens its grip on urban space and market order.
China’s Under-the-Counter Injectables: The Dangerous Proliferation of DIY Medical Aesthetics
An investigation has uncovered that major Chinese e-commerce platforms are illegally selling Class III medical injectables directly to consumers. Driven by a trend of 'consumer downgrading,' this grey market bypasses professional oversight, leading to severe medical risks and exposing significant regulatory gaps in the platform economy.
Apple’s Intelligence Glitch: A Glimpse into the Tech Giant’s Regulatory Limbo in China
A server-side error briefly enabled Apple Intelligence features for iPhone users in China, revealing that the technical localized version is largely prepared despite a lack of regulatory clearance. The incident underscores the ongoing friction between Apple’s global AI ambitions and Beijing’s strict oversight of generative AI services.
Apple’s AI Ghost in the Machine: The Strategic Friction Behind the 'Quiet Launch' in China
Apple Intelligence briefly appeared for beta users in mainland China before being retracted, highlighting the technical readiness and ongoing regulatory hurdles facing the company's AI rollout in the region.